Redox control on the cell surface: Implications for HIV-1 entry

Antioxidants and Redox Signaling

Volumn 5, Issue 1, 2003, Pages 133-138

  Matthias, Lisa J ^b   Hogg, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CD4 ANTIGEN; DISULFIDE; GLYCOPROTEIN GP 120; PHOSPHODIESTERASE INHIBITOR; THIOL DERIVATIVE; THIOREDOXIN;

CELL SURFACE; DISULFIDE BOND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037296312     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603321223621     Document Type: Review

References (55)

1. Akagi S, Yamamoto A, Yoshimori T, Masaki R, Ogawa R, and Tashiro Y. Localization of protein disulfide isomerase on plasma membranes of rat exocrine pancreatic cells. J Histochem Cytochem 36: 1069-1074, 1988.
2. Bachelder RE, Bilancieri J, Lin W, and Letvin NL. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4. J Virol 69: 5734-5742, 1995.
3. Barbouche R, Miquelis R, Jones IM, and Fenouillet E. Protein disulfide isomerase-mediated reduction of two disulfide bonds of HIV Env gp120 occurs post CXCR4 binding and is required for fusion. J Biol Chem (epub ahead of print).
4. Bennett TA, Edwards BS, Sklar LA, and Rogelj S. Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes. J Immunol 164: 4120-4129, 2000.
5. Berridge MV, and Tan AS. High-capacity redox control at the plasma membrane of mammalian cells: transmembrane, cell surface, and serum NADH-oxidases. Antioxid. Redox Signal. 2: 231-242, 2000.
6. Booth C and Koch GL. Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell 59: 729-737, 1989.
7. 2-terminal domains. Science 260: 979-983, 1993.
8. Burgess JK, Hotchkiss KA, Suter C, Dudman NP, Szollosi J, Chesterman CN, Chong BH, and Hogg PJ. Physical proximity and functional association of glycoprotein 1bα and protein disulfide isomerase on the platelet plasma membrane. J Biol Chem 275: 9758-9766, 2000.
9. Burkly LC, Olson D, Shapiro R, Winkler G, Rosa JJ, Thomas DW, Williams C, and Chisholm P. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. J Immunol 149: 1779-1787, 1992.
10. Chen K, Lin Y, and Detwiler TC. Protein disulfide isomerase activity is released by activated platelets. Blood 79: 2226-2228, 1992.
11. Chow YH, Wei OL, Phogat S, Sidorov IA, Fouts TR, Broder CC, and Dimitrov DS. Conserved structures exposed in HIV-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and potential immunogens. Biochemistry 41: 7176-7182, 2002.
12. Couet J, de Bernard S, Loosfelt H, Saunier B, Milgrom E, and Misrahi M. Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry 35: 14800-14805, 1996.
13. Donoghue N, Yam PTW, Jiang X-M, and Hogg PJ. Presence of closely-spaced protein thiols on the surface of mammalian cells. Protein Sci 9: 2436-2445, 2000.
14. Essex DW, Chen K, and Swiatkowska M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood 86: 2168-2173, 1995.
15. Fenouillet E, Barbouche R, Courageot J, and Miquelis R. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding. J Infect Dis 183: 744-752, 2001.
16. Freedman RB, Klappa P, and Ruddock LW. Protein disulfide isomerases exploit synergy between catalytic and specific binding domains. EMBO Rep 3: 136-140, 2002.
17. Gallina A, Mandel R, Trahey M, Broder CC, and Ryser HJ. Inhibitors of protein disulfide isomerase (PDI) prevent cleavage of disulfide bonds in receptor-bound gp120 and prevent HIV-1 entry. J Biol Chem 277: 50579-50588, 2002.
18. Haebel PW, Goldstone D, Katzen F, Beckwith J, and Metcalf P. The disulfide-bond isomerase DsbC is activated by an immunoglobulin-fold thiol oxidoreductase: crystal structure of the DsbC-DsbDalpha complex. EMBO J 21: 4774-4784, 2002.
19. Harris RJ, Chamow SM, Gregory TJ, and Spellman MW. Characterization of a soluble form of human CD4. Eur J Biochem 188: 291-300, 1990.
20. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
21. Jiang X-M, Fitzgerald M, Grant CM, and Hogg PJ. Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J Biol Chem 274: 2416-2423, 1999.
22. Katz BA and Kossiakoff A. The crystallographically determined structures of atypical strained disulfides engineered into subtilisin. J Biol Chem 261: 15480-15485, 1986.
23. Kroning H, Kahne T, Ittenson A, Franke A, and Ansorge S. Thiol-proteindisulfide-oxidoreductase (proteindisulfide isomerase): a new plasma membrane constituent of mature human B lymphocytes. Scand J Immunol 39: 346-350, 1994.
24. Lawrence DA, Song R, and Weber P. Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation. J Leukoc Biol 60: 611-618, 1996.
25. Lay AJ, Jiang X-M, Daly E, Sun L, and Hogg PJ. Plasmin reduction by phosphoglycerate kinase is a thiol -independent process. J Biol Chem 277: 9062-9068, 2002.
26. Lynch GW, Sloane AJ, Rasco V, Lai A, and Cunningham AL. Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells. Eur J Immunol 29: 2590-2602, 1999.
27. Maddon PJ, Littman DR, Godfrey M, Maddon DE, Chess L, and Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42: 93-104, 1985.
28. Mandel R, Ryser HJ, Ghani F, Wu M, and Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci U S A 90: 4112-4116, 1993.
29. Martin H and Dean M. Identification of a thioredoxin-related protein associated with plasma membranes. Biochem Biophys Res Commun 175: 123-128, 1991.
30. Matthias LJ, Yam PTW, Jiang X-M, Vandergraaff N, Li P, Poumbourios P, Donoghue N, and Hogg PJ. Disulfide exchange in domain 2 of CD4 is required for entry of the human immunodeficiency virus type 1. Nat Immunol 3: 727-732, 2002.
31. Miller MD and Hazuda DJ. New antiretroviral agents: looking beyond protease and reverse transcriptase. Curr Opin Microbiol 4: 535-539, 2001.
32. + cells. J Virol 66: 4784-4793, 1992.
33. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, Herzenberg LA, and Herzenberg LA. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8: 603-611, 1996.
34. Nakamura H, De Rosa SC, Yodoi J, Holmgren A, Ghezzi P, Herzenberg LA, and Herzenberg LA. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci U S A 98: 2688-2693, 2001.
35. Noiva R. Enzymatic catalysis of disulfide formation. Protein Expr Purif 5: 1-13, 1994.
36. 1 with zero, one, and two intact disulfide-bonds. J Biol Chem 263: 11820-11825, 1988.
37. Ramachandran N, Root P, Jiang XM, Hogg PJ, and Mutus B. Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc Natl Acad Sci U S A 98: 9539-9544, 2001.
38. Richardson JA. Protein anatomy. Adv Protein Chem 34: 167-339, 1981.
39. Rubartelli A, Bajetto A, Allavena G, Wollman E, and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 267: 24161-24164, 1992.
40. Ryser HJ-P, Levy EM, Mandel R, and DiSciullo GJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci U S A 91: 4559-4563, 1994.
41. Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai XP, Xuong NH, Axel R, Sweet RW, and Hendrickson WA. Crystal structure of an HIV-binding recombinant fragment of human CD4, Nature 348: 419-426, 1990.
42. Sanejouand YH. Normal-mode analysis suggests important flexibility between the two N-terminal domains of CD4 and supports the hypothesis of a conformational change in CD4 upon HIV binding. Protein Eng 9: 671-677, 1996.
43. Soderberg A, Sahaf B, and Rosen A. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res 60: 2281-2289, 2000.
44. Sodroski JG. HIV-1 entry inhibitors in the side pocket. Cell 99: 243-246, 1999.
45. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, and Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of a dithiol -reduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989.
46. Tager M, Kroning H, Thiel U, and Ansorge S. Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Exp Hematol 25: 601-607, 1997.
47. Terada K, Manchikalapudi P, Noiva R, Jauregui HO, Stockert RJ, and Schilsky ML. Secretion, surface localization, turnover, and steady state expression of protein disulfide isomerase in rat hepatocytes. J Biol Chem 270: 20410-20416, 1995.
48. Thornton JM. Disulphide bridges in globular proteins. J Mol Biol 151: 261-287, 1981.
49. Wang JH, Yan YW, Garrett TP, Liu JH, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, and Harrison SC. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348: 411-418, 1990.
50. Weiner SJ, Kollman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S Jr, and Weiner P. A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 106: 765-784, 1984.
51. Wells JA and Power DB. In vivo formation and stability of engineered disulfide bonds in subtilism. J Biol Chem 261: 6564-6570, 1986.
52. Wetzel R. Harnessing disulfide-bonds using protein engineering. Trends Biochem Sci 12: 478-482, 1987.
53. Woolman EE, Kahan A, and Fradelizi D. Detection of membrane associated thioredoxin on human cell lines. Biochem Biophys Res Commun 230: 602-606, 1997.
54. Yoshimori T, Semba T, Takemoto H, Akagi S, Yamamoto A, and Tashiro Y. Protein disulfide-isomerase in rat exocrine pancreatic cells is exported from the endoplasmic reticulum despite possessing the retention signal. J Biol Chem 265: 15984-15990, 1990.
55. Zai A, Rudd MA, Scribner AW, and Loscalzo J. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest 103: 393-399, 1999.